Commentary: Treatment Considerations for Patients With Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Brain Metastases in the Era of Tyrosine Kinase Inhibitors

Department of Neurosurgery, Stanford University School of Medicine Stanford, California

Department of Radiation Oncology, Stanford University School of Medicine Stanford, California

Department of Medicine, Division of Oncology, Stanford University School of Medicine Stanford, California

Correspondence: Melanie Hayden Gephart, MD, MAS, Department of Neurosurgery, Stanford University, 300 Pasteur Drive, MC 5327, Stanford, CA 94305. E-mail: [email protected]